Reported 3,225,000 shares, down 775,000 (19.4%) from the prior quarter.
Reported value -27.2%; share count -19.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-06-30 | 5015000 |
| 2025-09-30 | 23745200 |
| 2025-12-31 | 58982000 |
| 2026-03-31 | 127400000 |
| 2026-06-30 | 203000000 |
| 2026-09-30 | 147834000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 3,225,000 | -775,000 (-19.4%) | 3.82% | $147,834,000 | 2026-11-16 | |
| Q2 2026 | Added | 4,000,000 | +750,000 (23.1%) | 4.74% | $203,000,000 | 2026-08-14 | |
| Q1 2026 | Reduced | 3,250,000 | -580,000 (-15.1%) | 3.56% | $127,400,000 | 2026-05-15 | |
| Q4 2025 | Added | 3,830,000 | +2,670,000 (230.2%) | 2.01% | $58,982,000 | 2026-02-17 | |
| Q3 2025 | Added | 1,160,000 | +910,000 (364.0%) | 1.07% | $23,745,200 | 2025-11-14 | |
| Q2 2025 | New | 250,000 | +250,000 (0.0%) | 0.26% | $5,015,000 | 2025-08-14 |
Who else reported the position
245 managers reported ENLIVEN THERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 10,827,727 | +802,710 | 0.02% | $496,343,006 | 15 qtrs |
| ORBIMED ADVISORS LLC | Unchanged | 6,776,632 | 0 | 5.67% | $310,640,811 | 15 qtrs |
| Polar Capital Holdings Plc | Reduced | 6,425,271 | -5,365 | 0.71% | $294,534,423 | 10 qtrs |
| BlackRock Inc | Added | 5,711,966 | +1,352,262 | < 0.01% | $261,836,522 | 9 qtrs |
| COMMODORE CAPITAL LP | Unchanged | 3,275,000 | 0 | 11.63% | $150,126,000 | 15 qtrs |
| Vestal Point Capital LP This report | Reduced | 3,225,000 | -775,000 | 3.82% | $147,834,000 | 6 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 2,893,109 | +324,107 | < 0.01% | $132,620,117 | 3 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Reduced | 2,350,207 | -553,700 | 0.01% | $107,735,000 | 10 qtrs |
| Fairmount Funds Management LLC | Unchanged | 1,855,644 | 0 | 5.33% | $85,062,721 | 15 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 1,708,920 | +301,718 | < 0.01% | $78,351,951 | 15 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 3,225,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.